What are the best treatments for Sjogren?

The treatment of Sjogren is highly personalized and focuses on managing symptoms and controlling systemic inflammation, as there is currently no cure for the condition.

First-Line and Pharmacological Treatments

Treatment for Sjogren is categorized into symptomatic relief and systemic disease management. For sicca symptoms (dry eyes and mouth), first-line care often involves artificial tears, ocular lubricants, and prescription eye drops like cyclosporine (Restasis) or lifitegrast (Xiidra). For dry mouth, saliva substitutes and sialagogues such as pilocarpine (Salagen) or cevimeline (Evoxac) are commonly used to stimulate moisture production.

When Sjogren involves systemic manifestations—such as joint pain, vasculitis, or internal organ involvement—rheumatologists may prescribe immunomodulatory therapies. These include hydroxychloroquine (Plaquenil) to address fatigue and joint pain, and in more severe cases, immunosuppressants like methotrexate, azathioprine, or biologic agents like rituximab (Rituxan) to quiet the overactive immune system.

Non-Pharmacological and Multidisciplinary Care

Because Sjogren is a systemic condition, a multidisciplinary care team is essential. Your team should ideally include a rheumatologist (the primary lead), an ophthalmologist for corneal protection, a dentist specializing in xerostomia to prevent tooth decay, and a neurologist if peripheral neuropathy occurs. Non-pharmacological approaches, such as specialized dental hygiene routines, humidifiers for dry nose and sinus issues, and physical therapy for joint pain, are vital components of a comprehensive care plan.

Variability and Emerging Research

Effectiveness varies significantly between patients; some individuals experience mild sicca symptoms, while others face debilitating systemic complications. Research is currently active, with various clinical trials investigating targeted B-cell therapies and novel anti-inflammatory pathways to better treat the underlying immune dysfunction of Sjogren. Always consult your medical team to tailor these options to your specific clinical presentation, as treatment must be individualized based on your unique progression of Sjogren.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• Sjogren’s Foundation (Sjogrens.org)